Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma ; volume:12 ; number:1 ; day:19 ; month:10 ; year:2017 ; pages:1-8 ; date:12.2017
Radiation oncology ; 12, Heft 1 (19.10.2017), 1-8, 12.2017
- Creator
-
Moore, Assaf
- Contributor
-
Cohen-Naftaly, Michal
Tobar, Anna
Kundel, Yulia
Benjaminov, Ofer
Braun, Marius
Issachar, Assaf
Mor, Eytan
Sarfaty, Michal
Bragilovski, Dimitri
Hur, Ran Ben
Gordon, Noa
Stemmer, Salomon M.
Allen, Aaron M.
SpringerLink (Online service)
- DOI
-
10.1186/s13014-017-0899-4
- URN
-
urn:nbn:de:101:1-2018091316580967226431
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moore, Assaf
- Cohen-Naftaly, Michal
- Tobar, Anna
- Kundel, Yulia
- Benjaminov, Ofer
- Braun, Marius
- Issachar, Assaf
- Mor, Eytan
- Sarfaty, Michal
- Bragilovski, Dimitri
- Hur, Ran Ben
- Gordon, Noa
- Stemmer, Salomon M.
- Allen, Aaron M.
- SpringerLink (Online service)
Other Objects (12)
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"
Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC)
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"
Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC)
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"
Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC)
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma